Australia Markets close in 5 hrs 36 mins

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
67.62+0.11 (+0.16%)
At close: 01:40PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.42
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 381.44
52-week low 365.28
50-day moving average 370.79
200-day moving average 373.33

Share statistics

Avg vol (3-month) 38.26M
Avg vol (10-day) 310.34M
Shares outstanding 52.13B
Implied shares outstanding 6N/A
Float 82.12B
% held by insiders 10.07%
% held by institutions 179.40%
Shares short (12 Jan 2023) 420.96M
Short ratio (12 Jan 2023) 42.29
Short % of float (12 Jan 2023) 40.99%
Short % of shares outstanding (12 Jan 2023) 40.99%
Shares short (prior month 14 Dec 2022) 424.88M

Dividends & splits

Forward annual dividend rate 42.28
Forward annual dividend yield 43.10%
Trailing annual dividend rate 31.88
Trailing annual dividend yield 32.78%
5-year average dividend yield 42.98
Payout ratio 474.24%
Dividend date 330 Apr 2023
Ex-dividend date 404 Jan 2023
Last split factor 21000000:951777
Last split date 306 Aug 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022

Profitability

Profit margin 13.71%
Operating margin (ttm)19.72%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)18.46%

Income statement

Revenue (ttm)46.16B
Revenue per share (ttm)21.67
Quarterly revenue growth (yoy)-4.80%
Gross profit (ttm)36.02B
EBITDA 19.55B
Net income avi to common (ttm)6.33B
Diluted EPS (ttm)-2.76
Quarterly earnings growth (yoy)-14.80%

Balance sheet

Total cash (mrq)9.03B
Total cash per share (mrq)4.25
Total debt (mrq)40.17B
Total debt/equity (mrq)122.72
Current ratio (mrq)N/A
Book value per share (mrq)16.84

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A